Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple SclerosisJelle Y. Broos, Gijs Kooij, Bernard M.J. Uitdehaag et al.|Neurology|2023Cited by 24
State Changes During Resting-State (Magneto)encephalographic Studies: The Effect of Drowsiness on Spectral, Connectivity, and Network AnalysesEva Strijbis, Cornelis J. Stam, Yannick S. S. Timar et al.|Frontiers in Neuroscience|2022Cited by 20
Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple SclerosisFloor C. Loonstra, Joep Killestein, Lodewijk R. J. de Ruiter et al.|Neurology Neuroimmunology & Neuroinflammation|2022Cited by 18
Adipokines in multiple sclerosis patients are related to clinical and radiological measuresFloor C. Loonstra, Merel Rijnsburger, Kim Falize et al.|Journal of Neurology|2022Cited by 15
Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohortLodewijk R. J. de Ruiter, Bernard M.J. Uitdehaag, Floor C. Loonstra et al.|Multiple Sclerosis and Related Disorders|2023Cited by 11